This week's guests: Michael Riotto and Bill Smith
This week’s podcast is all about the QALY and the bill going to the Senate that would ban its use.
The QALY is a metric used to determine how cost-effective a treatment is based on its ability to return a sick person to perfect health. Even if a treatment helps a chronically ill person to live longer, it will not be categorized as valuable as treatments are aimed at diseases that affect younger and healthier populations.
To help us understand how the QALY negatively impacts those with chronic illness,
we’re joined by Michael Riotto, a member of Patients Rising, and Bill Smith, a Senior Fellow at the Pioneer Institute.
